Latest IPOs
| Inovio Biomedical to merge with VGX Pharmaceuticals |
| Inovio Biomedical, a developer of electroporation-based DNA vaccine delivery technology has decided to merge with GX Pharmaceuticals, a privately held DNA vaccine developer. The merger, when fructifies, will provide for the issuance of Inovio Biomedical |
More
-
Dubai-based Damas raises $270.6m in IPO
(MENAFN) The Dubai-based jeweler, Damas International Ltd. said in a statement that the company has recently raised $270.6 million in an initial public offering (IPO) from an initial share sale after ...
-
Eli Lilly denies NYT report on Zyprexa
NEW YORK (Reuters) - Eli Lilly and Co on Friday denied a report in The New York Times that said a senior executive had encouraged the promotion of its schizophrenia drug Zyprexa for a use not approved...